The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Does This Patient Have Temporal Arteritis?
Abstract
CONTEXT: Clinicians must be able to confidently diagnose temporal arteritis (TA), since failure to make a correct diagnosis may lead to irreversible visual loss as well as inappropriate evaluation and treatment of headache, fatigue, and other potential presenting symptoms. The diagnostic value of particular signs and symptoms among patients with suspected TA is unknown. OBJECTIVE: To determine the accuracy of historical features, physical examination, and erythrocyte sedimentation rate (ESR) in diagnosis of TA. DATA SOURCES: We performed a MEDLINE search of English-language articles published between January 1966 and July 2000 and a hand search of bibliographies of retrieved articles, previous reviews, monographs, and textbooks. STUDY SELECTION: Studies that provided detailed clinical information on patients who had been referred for temporal artery biopsy. Of 114 studies retrieved, 41 met our inclusion criteria; 21 included both biopsy-positive and biopsy-negative patients and formed the core of our review. DATA EXTRACTION: Both authors independently reviewed each study to determine eligibility, abstracted data using a standardized instrument, and classified study quality using predetermined criteria. DATA SYNTHESIS: The prevalence of TA in the general population is less than 1%. However, in our 21 core studies, 39% of patients referred for temporal artery biopsy had positive results. The only 2 historical features that substantially increased the likelihood of TA among patients referred for biopsy were jaw claudication (positive likelihood ratio [LR], 4.2; 95% confidence interval [CI], 2.8-6.2) and diplopia (positive LR, 3.4; 95% CI, 1.3-8.6). The absence of any temporal artery abnormality was the only clinical factor that modestly reduced the likelihood of disease (negative LR, 0.53; 95% CI, 0.38-0.75). Predictive physical findings included temporal artery beading (positive LR, 4.6; 95% CI, 1.1-18.4), prominence (positive LR, 4.3; 95% CI, 2.1-8.9), and tenderness (positive LR, 2.6; 95% CI, 1.9-3.7). Normal ESR values indicated much less likelihood of disease (negative LR for abnormal ESR, 0.2; 95% CI, 0.08-0.51). CONCLUSIONS: A small number of clinical features are helpful in predicting the likelihood of a positive temporal artery biopsy among patients with a clinical suspicion of disease; the most useful finding is a normal ESR, which makes TA unlikely.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330810 · Cited by 2,539
Ocular manifestations of giant cell arteritis
Hayreh, S. S., Podhajsky, P. A., & Zimmerman, B. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80192-5 · Cited by 571
Giant Cell Arteritis: Validity and Reliability of Various Diagnostic Criteria
HAYREH, S. S., PODHAJSKY, P. A., RAMAN, R., & ZIMMERMAN, B. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70123-0 · Cited by 412
González-Gay, M. A., Blanco, R., Rodríguez-Valverde, V., Martínez-Taboada, V. M., Delgado-Rodriguez, M., Figueroa, M., & Uriarte, E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8<1497::aid-art22>3.0.co;2-z · Cited by 408
Visual Prognosis in Giant Cell Arteritis
Aiello, P. D., Trautmann, J. C., McPhee, T. J., Kunselman, A. R., & Hunder, G. G. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31608-8 · Cited by 388
Achkar, A. A., Lie, J. T., Hunder, G. G., O'Fallon, W. M., & Gabriel, S. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00003 · Cited by 366
Roche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., & Weyand, C. M. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360913 · Cited by 347
Salvarani, C., Gabriel, S. E., O'Fallon, W. M., & Hunder, G. G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00006 · Cited by 344
Temporal Arteritis and Polymyalgia Rheumatica: Clinical and Biopsy Findings
FAUCHALD, P., RYGVOLD, O., & ØYSTESE, B. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-6-845 · Cited by 298
Visual Morbidity in Giant Cell Arteritis
Liu, G. T., Glaser, J. S., Schatz, N. J., & Smith, J. L. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31102-x · Cited by 259
Simple rule for calculating normal erythrocyte sedimentation rate.
Miller, A., Green, M., & Robinson, D. (1983) · BMJ · doi:10.1136/bmj.286.6361.266 · Cited by 258
Does This Patient Have Abdominal Aortic Aneurysm?
Lederle, F. A. (1999) · JAMA · doi:10.1001/jama.281.1.77 · Cited by 222
ARTERITIS OF THE TEMPORAL VESSELS: A PREVIOUSLY UNDESCRIBED FORM
HORTON, B. T. (1934) · Archives of Internal Medicine · doi:10.1001/archinte.1934.00160090077007 · Cited by 213
Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a danish county
Boesen, P., & Sørensen, S. F. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300308 · Cited by 203
Giant cell arteritis in Iceland.
Baldursson, Ó., Steinsson, K., Björnsson, J., & Lie, J. T. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370705 · Cited by 189
Does the Clinical Examination Predict Airflow Limitation?
Holleman, D. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520280059041 · Cited by 187
Proximal Bursitis in Active Polymyalgia Rheumatica
Salvarani, C., Cantini, F., Olivieri, I., Barozzi, L., Macchioni, L., Niccoli, L., Padula, A., De Matteis, M., & Pavlica, P. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-1-199707010-00005 · Cited by 158
Matteson, E. L., Gold, K. N., Bloch, D. A., & Hunder, G. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89458-2 · Cited by 150
MeWAnalysis by the Confidence Profile Method: The Statistical Synthesis of Evidence
Lenth, R. V., Eddy, D. M., Hasselblad, V., & Shachter, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10485067 · Cited by 148
Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality.
González-Gay, M. Á., Blanco, R., Abraira, V., García-Porrúa, C., Ibáñez, D., García-Pais, M. J., Rigueiro, M. T., Sanchez-Andrade, A., Guerrero, J., & Casariego, E. (1997) · PubMed · Cited by 96
FAST PRO : software for meta-analysis by the confidence profile method
Eddy, D. M., & Hasselblad, V. (1992) · Academic Press eBooks · Cited by 68
Prognosis of polymyalgia rheumatica and giant cell arteritis
Myles, A. B. (1991) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80068-8 · Cited by 6
Lawrence (1998) · doi:10.1002/1529-0131(199805)41:5<778::aid-art4>3.0.co;2-v
Cited by
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
Polymyalgia rheumatica and giant-cell arteritis
Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61077-6 · Cited by 767
Polymyalgia Rheumatica and Giant Cell Arteritis
Ettlinger, R. E., Hunder, G. G., & Ward, L. E. (1978) · Annual Review of Medicine · doi:10.1146/annurev.me.29.020178.000311 · Cited by 687
Does This Adult Patient Have Septic Arthritis?
Margaretten, M. E., Kohlwes, J., Moore, D., & Bent, S. (2007) · JAMA · doi:10.1001/jama.297.13.1478 · Cited by 640
BSR and BHPR guidelines for the management of giant cell arteritis
Dasgupta, B., Borg, F. A., Hassan, N., Alexander, L., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., James, P., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq039a · Cited by 444
Metadata
- Authors
- Smetana, G. W.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-01-02
- Volume
- 287
- Issue
- 1
- Pages
- 92
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2019754280
- Cited by
- 402
- References
- 23
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.